Benjamin Edwards Inc’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.9M | Buy |
224,529
+59,854
| +36% | +$7.01M | 0.26% | 108 |
|
|
2026
Q1 | $19.8M | Sell |
164,675
-307,869
| -65% | -$35.5M | 0.2% | 133 |
|
|
2025
Q4 | $49.7M | Sell |
472,544
-21,391
| -4% | -$2.01M | 0.55% | 40 |
|
|
2025
Q3 | $41.5M | Buy |
493,935
+19,680
| +4% | +$1.62M | 0.47% | 60 |
|
|
2025
Q2 | $37.5M | Buy |
474,255
+29,628
| +7% | +$2.36M | 0.48% | 63 |
|
|
2025
Q1 | $39.9M | Buy |
444,627
+53,177
| +14% | +$4.96M | 0.56% | 54 |
|
|
2024
Q4 | $38.9M | Buy |
391,450
+9,701
| +3% | +$1M | 0.56% | 47 |
|
|
2024
Q3 | $43.4M | Buy |
381,749
+353,692
| +1,261% | +$42M | 0.63% | 39 |
|
|
2024
Q2 | $3.47M | Buy |
28,057
+264
| +0.9% | +$34K | 0.67% | 30 |
|
|
2024
Q1 | $3.67M | Sell |
27,793
-2,359
| -8% | -$291K | 0.73% | 29 |
|
|
2023
Q4 | $3.29M | Sell |
30,152
-86
| -0.3% | -$8.93K | 0.72% | 37 |
|
|
2023
Q3 | $3.11M | Sell |
30,238
-2,349
| -7% | -$253K | 0.74% | 38 |
|
|
2023
Q2 | $3.76M | Sell |
32,587
-4,148
| -11% | -$471K | 0.87% | 25 |
|
|
2023
Q1 | $3.91M | Sell |
36,735
-3,266
| -8% | -$353K | 0.95% | 19 |
|
|
2022
Q4 | $4.44M | Buy |
40,001
+4,163
| +12% | +$426K | 1.17% | 13 |
|
|
2022
Q3 | $3.09M | Buy |
35,838
+1,381
| +4% | +$123K | 0.93% | 28 |
|
|
2022
Q2 | $3.14M | Buy |
34,457
+4,560
| +15% | +$404K | 0.92% | 25 |
|
|
2022
Q1 | $2.45M | Buy |
29,897
+6,127
| +26% | +$483K | 0.71% | 35 |
|
|
2021
Q4 | $1.82M | Buy |
23,770
+9,221
| +63% | +$734K | 0.59% | 43 |
|
|
2021
Q3 | $1.09M | Buy |
14,549
+6,244
| +75% | +$475K | 0.66% | 45 |
|
|
2021
Q2 | $646K | Sell |
8,305
-1,329
| -14% | -$98.9K | 0.44% | 90 |
|
|
2021
Q1 | $709K | Buy |
9,634
+477
| +5% | +$35.2K | 0.54% | 75 |
|
|
2020
Q4 | $715K | Buy |
9,157
+297
| +3% | +$22.7K | 0.55% | 72 |
|
|
2020
Q3 | $701K | Buy |
8,860
+500
| +6% | +$39.2K | 0.58% | 61 |
|
|
2020
Q2 | $617K | Sell |
8,360
-371
| -4% | -$27.9K | 0.51% | 67 |
|
|
2020
Q1 | $641K | Buy |
8,731
+6,649
| +319% | +$523K | 0.67% | 47 |
|
|
2019
Q4 | $181K | Buy |
2,082
+88
| +4% | +$7.23K | 0.37% | 58 |
|
|
2019
Q3 | $160K | Buy |
1,994
+292
| +17% | +$23.4K | 0.35% | 59 |
|
|
2019
Q2 | $136K | Buy |
1,702
+291
| +21% | +$22.3K | 0.33% | 64 |
|
|
2019
Q1 | $112K | Buy |
+1,411
| New | +$106K | 0.54% | 45 |
|
Other funds holding MRK
Benjamin Edwards Inc's MRK Position: Q2 2026 in Review
Benjamin Edwards Inc increased its Merck (MRK) stake by 36% in Q2 2026, buying an estimated $7.01M and bringing the position to 224,529 shares worth $28.9M. The position accounts for 0.26% of the portfolio, ranked #108.
Benjamin Edwards Inc first reported a position in MRK in Q1 2019 and has held it in 30 quarters since. The position peaked at $49.7M in Q4 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Benjamin Edwards Inc held 224,529 shares of Merck worth $28.9M as of Q2 2026.
- Benjamin Edwards Inc bought 59,854 Merck shares in Q2 2026, an estimated $7.01M.
- Merck made up 0.26% of Benjamin Edwards Inc's portfolio in Q2 2026, its #108 holding.
- Benjamin Edwards Inc first reported a position in Merck in Q1 2019 and has held it in 30 quarters since.
- Benjamin Edwards Inc's Merck position peaked at $49.7M in Q4 2025.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.